Because of their access to medicine prices and their expertise in the existing pharmaceutical systems, experts of the Pharmacoeconomics Department have been conducting research on medicine prices (international medicine price comparisons, impact of discounts and rebates, the relevance of wholesale and pharmacy remuneration as part of medicine prices) and have been providing technical support and trainings to policy-makers on these issues.
Selection of studies:
- Schneider P, Vogler S, Zimmermann N, Zuba M (2018): Preisvergleich ausgabenstarker Arzneispezialitäten 2017 [Price comparison of high-cost pharmaceuticals 2017]. Vienna; Gesundheit Österreich GmbH
- Zuba M, Habl C, Nemeth G (2018): EURIPID Study on the Calculation of Purchasing Power Parities (PPPs) for pharmaceutical products. Written in the framework of Contract N°: PN5C/06/2016/C4 supported by Eurostat LINK
- Vogler S, Babar Z-U-D, Vitry A (2016): Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study. Lancet Oncology 17(1): 39-47, 2016
- Vogler S, Zimmermann N, Babar Z-U-D (2016): Price comparison of high-cost originator medicines in European countries. Expert Review of Pharmacoeconomics & Outcomes 17 (2): 221-230
- Vogler S, Zimmermann N, Leopold C, Habl C, Mazag J (2013): Discounts and Rebates Granted for Medicines for Hospital Use in Five European Countries. Open Pharmacoeconomics & Health Economics 5: 1-10
- Vogler S, Zimmermann N, Habl C, Mazag J (2013): The role of discounts and loss leaders in medicine procurement in Austrian hospitals - a primary survey of official and actual medicine prices. Cost Effectiveness and Resource Allocation 11:
- For further studies see: https://ppri.goeg.at/publications
Content of training sessions (selection):
- Where and how to source medicine price data, and how to assess the feasibility and quality of a data source?
- How to provide a medicine price study (methodological choices)?
- How to interpret findings of medicine price studies?
- How to perform international medicine price comparisons: shortfall and prerequisite
- Using medicine price data for pricing medicines: how to design the policy of external price referencing?
- For further information see: https://ppri.goeg.at/trainings